INDOCO.BO

Indoco Remedies Limited INDOCO.BO

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode INDOCO.BO MOREPENLAB.NS MOREPENLAB.BO ALEMBICLTD.NS SOLARA.NS IOLCP.BO SOLARA.BO IOLCP.NS HIKAL.BO HIKAL.NS
6M 16.98 % -9.78 % -9.83 % -3.55 % 15.01 % 41.47 % 14.75 % 41.23 % -40.80 % -40.69 %
YTD -13.26 % -37.93 % -37.96 % -22.58 % -14.44 % 15.83 % -14.44 % 15.63 % -39.65 % -39.49 %
1Y -10.92 % -36.58 % -36.60 % -15.73 % -23.19 % 21.73 % -23.36 % 21.64 % -30.26 % -30.10 %
3Y -15.82 % 82.37 % 83.47 % 51.27 % 57.18 % 31.75 % 49.23 % 31.48 % -24.84 % -24.81 %
5Y 10.84 % 86.17 % 85.90 % 6.28 % -42.71 % -29.89 % -42.76 % -29.82 % 48.67 % 48.90 %
10Y -14.82 % 194.31 % 194.61 % 180.37 % 158.64 % 493.71 % 137.88 % 492.47 % 164.26 % 165.03 %
From the beginning 445.36 % 141.17 % -67.22 % 2 451.24 % 158.64 % 10 065.25 % 137.88 % 758.75 % 468.19 % 2 415.48 %

Dividend

Indoco Remedies Limited

Morepen Laboratories Limited

Morepen Laboratories Limited

Alembic Limited

Solara Active Pharma Sciences Limited

IOL Chemicals and Pharmaceuticals Limited

Solara Active Pharma Sciences Limited

IOL Chemicals and Pharmaceuticals Limited

Hikal Limited

Hikal Limited